Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms by Site
×
exemestane
×
Clear all
Filters
3
NCT05768139
2026-03-02
PIKALO-1
Eli Lilly and Company
Phase 1/2
Recruiting
720 enrolled
NCT01594398
2021-11-19
ENCORE110
Syndax Pharmaceuticals
Phase 1
Completed
14 enrolled